Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1

<div>A receiver operator characteristics curve analysis with different factors for assessing the progression of atrial fibrillation. (a) Tissue inhibitor of matrix metalloproteinase (TIMP-1) and soluble suppression of tumorigenicity 2 protein (sST2) individually. (b) TIMP-1 and sST2 combined. (c) TIMP-1, sST2, brain natriuretic peptide (BNP), and left atrial diameter (LAD) combined. (d) TIMP-1, sST2, BNP, LAD, age, and gender combined.</div>

International Journal of Clinical Practice

fig4

Figure 4

Figure 4: Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1 

Figure 4 | Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1 